Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients: BSH Good Practice Paper

The British Society for Haematology (BSH) and the UK Myeloma Society have published a comprehensive Good Practice Paper on the diagnosis and initial treatment of transplant-eligible high-risk myeloma patients. Authored by leading experts in the field, this paper provides crucial recommendations based on the latest genetic diagnostics and prospective clinical trial evidence for high-risk myeloma.…

Clinical guidelines & position statements, Library, Management & Treatment

International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

Step into the forefront of myeloma treatment with this latest publication from the International Myeloma Working Group immunotherapy committee. Discover the groundbreaking world of immunotherapy, where innovations like CAR T-cell therapy and bispecific antibodies are reshaping myeloma treatment. An expert panel provides exclusive insights and tailored recommendations, guiding the way to optimised patient care. Ready…

Clinical guidelines & position statements, Library, Management & Treatment

Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper

Explore the latest guidelines for Smouldering Myeloma care in the British Society for Haematology Good Practice Paper. Discover evidence-based recommendations, including clear patient support, tailored vaccination strategies, and more. For a comprehensive overview, access the full paper here.

 

Clinical guidelines & position statements, Library, Management & Treatment